Ann: Update on Novartis Agreement, page-581

@Zenox
Like I said, I'm probably wrong. Needless to say, I hope I am.

But that is kind of what they have to say, as they can't exactly reference information that hasn't been shared publicly by Mesoblast.

The disclosure thus far by management on the termination by Novartis has been poor, but IMO all will be forgotten if the OTAT outcome is positive and they can lodge the Ryoncil BLA as well as initiate the COVID ARDS phase 3 trial.

For now, that is all Mesoblast can do. Push forward and demonstrate by running that phase 3 COVID ARDs trial and letting the data speak for itself. And if Novartis come calling again, SI may just let it go to voicemail.